Infectious Disease Division
The Infectious Diseases (ID) Division, Department of Medicine, spans the globe with approximately 165 faculty appointments. Many faculty are assigned to military medical treatment facilities, providing patient care and clinical education including those at the three military infectious diseases training programs (National Capital Consortium, Bethesda MD; Naval Medical Center, San Diego CA; San Antonio Uniformed Services Health Education Consortium, San Antonio TX). Additionally, some ID faculty are assigned to the United States and overseas military research laboratories. Among USU-billeted Medicine ID faculty there are a range of research interests, including viruses (e.g. HIV, SARs-COV2), antimicrobial resistance, vaccines, and parasites as well as technical approaches of structural biology, immunology, and clinical trials.
Besides research, our ID faculty contribute to clinical education supporting USU medical student training, graduate programs, as well as training of post graduate physicians during residency and ID fellowship. All billeted ID physicians provide clinical care in military healthcare system, both outpatient and inpatient services in the National Capital Region.
OUR LAB
Please find more information about our laboratory here (Lab webpage)
Our Vision
Inspire academic excellence in ID across the Military Health System through collaboration, innovative discovery and scholarship, skilled clinical care, inclusive education, and mentorship that will translate to improved health care for those who defend us.
Our Mission
Execute School of Medicine/ Medicine Department mission to foster excellence in militarily relevant training, education and scholarship/discovery.
Faculty & Staff
Naomi Aronson M.D., MACP, FIDSA, Director, USU
Dr. Marzena Pazgier MS, PhD
Catherine Decker MD, FACP, FIDSA
Froilan Orille, Program Administrative Specialist, USU
COL Paul Robben, M.D., Ph.D., FACP: Deputy Director, Walter Reed Army Institute of Research
LABS
Infectious Disease- Aronson Lab
Infectious Disease- Pazgier Lab
Recent News:
Structure and inhibition of SARS-CoV-2 spike refolding in membranes
Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120